T. Rowe Price Associates’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-129,492
| Closed | -$15M | – | 2966 |
|
2023
Q3 | $15M | Sell |
129,492
-205,184
| -61% | -$23.7M | ﹤0.01% | 982 |
|
2023
Q2 | $34.4M | Sell |
334,676
-145,327
| -30% | -$14.9M | ﹤0.01% | 808 |
|
2023
Q1 | $52.4M | Sell |
480,003
-155,052
| -24% | -$16.9M | 0.01% | 677 |
|
2022
Q4 | $72.3M | Sell |
635,055
-154,700
| -20% | -$17.6M | 0.01% | 565 |
|
2022
Q3 | $48.9M | Sell |
789,755
-1,616
| -0.2% | -$100K | 0.01% | 654 |
|
2022
Q2 | $63.1M | Sell |
791,371
-24,740
| -3% | -$1.97M | 0.01% | 808 |
|
2022
Q1 | $85.9M | Sell |
816,111
-28,106
| -3% | -$2.96M | 0.01% | 783 |
|
2021
Q4 | $91M | Sell |
844,217
-9,974
| -1% | -$1.07M | 0.01% | 794 |
|
2021
Q3 | $93.6M | Sell |
854,191
-55,275
| -6% | -$6.05M | 0.01% | 792 |
|
2021
Q2 | $85.2M | Sell |
909,466
-167,237
| -16% | -$15.7M | 0.01% | 845 |
|
2021
Q1 | $99.1M | Sell |
1,076,703
-89,343
| -8% | -$8.22M | 0.01% | 780 |
|
2020
Q4 | $85.3M | Sell |
1,166,046
-828,040
| -42% | -$60.6M | 0.01% | 781 |
|
2020
Q3 | $155M | Sell |
1,994,086
-1,172,812
| -37% | -$91.1M | 0.02% | 544 |
|
2020
Q2 | $176M | Buy |
3,166,898
+1,265,351
| +67% | +$70.3M | 0.02% | 499 |
|
2020
Q1 | $56.3M | Buy |
1,901,547
+55,745
| +3% | +$1.65M | 0.01% | 746 |
|
2019
Q4 | $66.8M | Buy |
1,845,802
+230,772
| +14% | +$8.35M | 0.01% | 798 |
|
2019
Q3 | $44M | Buy |
1,615,030
+513,282
| +47% | +$14M | 0.01% | 914 |
|
2019
Q2 | $26.5M | Buy |
1,101,748
+1,042,969
| +1,774% | +$25.1M | ﹤0.01% | 1096 |
|
2019
Q1 | $1.55M | Buy |
58,779
+765
| +1% | +$20.2K | ﹤0.01% | 1668 |
|
2018
Q4 | $1.13M | Buy |
58,014
+380
| +0.7% | +$7.43K | ﹤0.01% | 1746 |
|
2018
Q3 | $1.13M | Sell |
57,634
-613
| -1% | -$12K | ﹤0.01% | 1833 |
|
2018
Q2 | $965K | Buy |
58,247
+666
| +1% | +$11K | ﹤0.01% | 1855 |
|
2018
Q1 | $818K | Buy |
57,581
+468
| +0.8% | +$6.65K | ﹤0.01% | 1867 |
|
2017
Q4 | $834K | Sell |
57,113
-23,635
| -29% | -$345K | ﹤0.01% | 1857 |
|
2017
Q3 | $1.02M | Sell |
80,748
-123,170
| -60% | -$1.56M | ﹤0.01% | 1789 |
|
2017
Q2 | $2.42M | Sell |
203,918
-333,002
| -62% | -$3.95M | ﹤0.01% | 1516 |
|
2017
Q1 | $7.94M | Buy |
536,920
+14,700
| +3% | +$217K | ﹤0.01% | 1371 |
|
2016
Q4 | $8.45M | Buy |
522,220
+13,200
| +3% | +$214K | ﹤0.01% | 1345 |
|
2016
Q3 | $9.23M | Buy |
509,020
+16,535
| +3% | +$300K | ﹤0.01% | 1331 |
|
2016
Q2 | $8.11M | Sell |
492,485
-10,797
| -2% | -$178K | ﹤0.01% | 1324 |
|
2016
Q1 | $8.34M | Buy |
503,282
+10,600
| +2% | +$176K | ﹤0.01% | 1307 |
|
2015
Q4 | $10.7M | Sell |
492,682
-26,220
| -5% | -$568K | ﹤0.01% | 1266 |
|
2015
Q3 | $10.3M | Sell |
518,902
-497,487
| -49% | -$9.86M | ﹤0.01% | 1300 |
|
2015
Q2 | $35.3M | Buy |
1,016,389
+154,389
| +18% | +$5.36M | 0.01% | 958 |
|
2015
Q1 | $22.4M | Sell |
862,000
-4,700
| -0.5% | -$122K | ﹤0.01% | 1089 |
|
2014
Q4 | $11.2M | Sell |
866,700
-17,400
| -2% | -$224K | ﹤0.01% | 1297 |
|
2014
Q3 | $10.9M | Sell |
884,100
-5,900
| -0.7% | -$72.5K | ﹤0.01% | 1284 |
|
2014
Q2 | $14.1M | Sell |
890,000
-12,400
| -1% | -$196K | ﹤0.01% | 1229 |
|
2014
Q1 | $13.6M | Buy |
902,400
+876,400
| +3,371% | +$13.3M | ﹤0.01% | 1219 |
|
2013
Q4 | $198K | Buy |
+26,000
| New | +$198K | ﹤0.01% | 2316 |
|